Articles
Diabetes Risk Factors & Prevention
Risk Factors
Risk factors are characteristics that can predispose you to developing a condition or disease. Just because you have one or more risk factors does...
Drug Research
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT (Amphetamine...
Neos Therapeutics, Inc, a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD) announced that...
Drug Research
FDA Approves Zepatier (elbasvir and grazoprevir) for Chronic Hepatitis...
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV)...
Articles
Teva’s Dedication and Commitment Recognized by Patients
Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups.
Teva's Dedication and...
Drug Research
AstraZeneca to collaborate with Cancer Research UK in screening...
AstraZeneca and Cancer Research UK today announced that they have signed a memorandum of understanding through which Cancer Research UK drug discovery investigators would be...
Drug Research
AstraZeneca and Orca Pharmaceuticals announce research collaboration to identify...
AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company, today announced a three year collaboration to develop inhibitors of retinoic acid–related orphan nuclear receptor gamma...
Drug Research
AstraZeneca supports crowd sourcing challenge to find new combination...
AstraZeneca is making available preclinical data from over 50 of its medicines as part of the DREAM Challenge, an open innovation competition, to find the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.